ARK Genomic Revolution ET... (ARKG)
26.66
0.10 (0.38%)
At close: Jan 28, 2025, 3:06 PM
undefined% (undefined)
| Bid | 26.66 |
| Market Cap | 1.05B |
| AUM | - |
| NAV | - |
| EPS (ttm) | 0.00 |
| PE Ratio (ttm) | n/a |
| Shares Out | 39.19M |
| Inception Date | Invalid Date |
| Ask | 26.67 |
| Volume | 1.49M |
| Open | 26.62 |
| Previous Close | 26.56 |
| Day's Range | 26.12 - 26.84 |
| 52-Week Range | 22.27 - 33.15 |
| Holdings | - |
| Expense Ratio | undefined% |
About ARKG
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
Asset Class Equity
Ticker Symbol ARKG
Inception Date Oct 31, 2014
Provider ARK
Website Fund Home Page
Top Holdings 34.50% of assets
| Company | Portfolio |
|---|---|
TWST Twist Bioscience Cor... | 9.64% |
RXRX Recursion Pharmaceut... | 6.99% |
CRSP Crispr Therapeutics ... | 6.58% |
TEM Tempus Ai, Inc. | 5.75% |
GH Guardant Health, Inc... | 5.54% |
